Olanzapine/risperidone and diabetes risk

被引：1
|
作者：
Lee, DW [1 ]
Fowler, RB [1 ]
机构：
[1] Protocare Sci, Herndon, VA USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 07期
关键词：
D O I：
10.4088/JCP.v64n0718a
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：847 / 848
页数：2
相关论文
共 50 条
  • [31] Cardiovascular risk associated with chronic treatment of paliperidone, olanzapine, risperidone and aripiprazole
    Montejo, A. L.
    Bermejo, C.
    Matias, J.
    Martin, T.
    Matias-Polo, J.
    Santana, Y.
    Lopez-Lopez, J.
    de Alarcon, R.
    Acosta, J. M.
    EUROPEAN PSYCHIATRY, 2024, 67 : S209 - S209
  • [32] Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia
    Kasper, S
    Möller, HJ
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 : 1 - 1
  • [33] Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics:: a population-based comparison of risperidone and olanzapine
    Moisan, J
    Grégoire, JP
    Gaudet, M
    Cooper, D
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (06) : 427 - 436
  • [34] Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
    Sidi He
    Wen Juan Yu
    Xiaoliang Wang
    Lei Zhang
    Nan Zhao
    Guanjun Li
    Yi Feng Shen
    Huafang Li
    上海精神医学, 2020, (04) : 194 - 200
  • [35] Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population
    Duncan, Erica J.
    Woolson, Sandra L.
    Hamer, Robert M.
    Dunlop, Boadie W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (04) : 204 - 213
  • [36] A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
    Ascher-Svanum H.
    Zhu B.
    Faries D.
    Ernst F.R.
    Annals of General Hospital Psychiatry, 3 (1):
  • [37] An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients
    Koro, CE
    Fedder, DO
    L'Italien, G
    Weiss, S
    Magder, LS
    Kreyenbuhl, J
    Revicki, D
    Buchanan, RW
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (11) : 1021 - 1026
  • [38] Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
    He, Sidi
    Yu, Wen Juan
    Wang, Xiaoliang
    Zhang, Lei
    Zhao, Nan
    Li, Guanjun
    Shen, Yi Feng
    Li, Huafang
    GENERAL PSYCHIATRY, 2020, 33 (04)
  • [39] Olanzapine/risperidone interactionLeucopenia: case report
    Reactions Weekly, 2018, 1701 (1) : 224 - 224
  • [40] RISPERIDONE AND OLANZAPINE IN TREATMENT OF DELUSIONAL DISORDERS
    Zivkovic, N.
    Bajovic, B.
    Djokic, G.
    Pavicevic, D.
    Nenadovic, M.
    EUROPEAN PSYCHIATRY, 2011, 26
12345